A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of New Plasmodium Falciparum Malaria Vaccine Candidates ChAd63 RH5 Alone and With MVA RH5
Clinical trial NCT02181088 · COMPLETED
Trial details
- NCT number
- NCT02181088
- Sponsor
- University of Oxford
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2015-10-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.